Key Points
- Gait impairment is usually the most prominent and most treatment-responsive feature of idiopathic NPH.
- The full triad of gait, cognition, and urinary incontinence is not required for diagnosis.
- Ventriculomegaly must be interpreted in relation to cortical atrophy and the overall imaging pattern; ventricular enlargement alone is not diagnostic.
- Exclude common mimics such as Parkinson disease, Alzheimer disease, vascular disease, spinal stenosis, neuropathy, arthritis, medication effects, and urologic disorders.
- Use objective gait measurements before and after CSF removal whenever possible.
- A positive tap test supports shunt responsiveness, but a negative test has limited sensitivity and does not absolutely exclude benefit.
- External lumbar drainage can provide additional predictive information when suspicion remains high despite an equivocal tap test.
- Ventriculoperitoneal shunting can meaningfully improve function but carries risks of hemorrhage, infection, overdrainage, obstruction, and revision.
Algorithm
- Identify progressive gait dysfunction with or without cognitive and urinary symptoms.
- Obtain MRI or CT brain and assess whether ventriculomegaly is disproportionate to atrophy and compatible with NPH morphology.
- Evaluate competing neurologic, orthopedic, medication, and urologic causes of the symptoms.
- Establish objective baseline gait and functional measures.
- Perform a large-volume lumbar tap test when appropriate and repeat standardized gait testing after drainage.
- If response is equivocal but suspicion remains high, consider external lumbar drainage or specialized CSF dynamics testing at an experienced center.
- Discuss expected benefits, uncertainty, and surgical complications with the patient and family.
- Proceed with shunt placement when the overall clinical, imaging, and physiologic evidence supports likely benefit.
- Monitor postoperatively for improvement, overdrainage, infection, obstruction, and subdural collections.
Clinical Synopsis & Reasoning
Idiopathic normal pressure hydrocephalus is a syndrome of ventricular enlargement associated with gait dysfunction, cognitive impairment, and urinary urgency or incontinence without sustained elevation of routine CSF opening pressure. The classic triad is useful as a memory aid but should not be treated as an all-or-none requirement. Gait disturbance is usually the earliest and most responsive feature: patients may have short steps, difficulty initiating, reduced foot clearance, a broad base, impaired turning, and a sense that the feet are stuck to the floor. Cognitive impairment is often frontal-subcortical, with slowed processing, impaired attention, apathy, and executive dysfunction rather than an isolated amnestic syndrome. Urinary urgency generally precedes frank incontinence.
Diagnosis is challenging because the same age group commonly has Alzheimer disease, vascular cognitive impairment, Parkinson disease, cervical or lumbar stenosis, neuropathy, arthritis, medication effects, sleep disorders, and urologic disease. Brain imaging should show ventriculomegaly disproportionate to cortical atrophy. Supportive features include narrowing of high-convexity sulci, enlarged Sylvian fissures, a reduced callosal angle, and the disproportionately enlarged subarachnoid-space hydrocephalus pattern. Periventricular signal change may reflect transependymal CSF flow or small-vessel disease and is not diagnostic by itself.
Objective pre- and post-drainage assessment is more informative than simply asking whether the patient feels better. A large-volume lumbar tap test commonly removes about 30 to 50 mL of CSF, followed by standardized gait testing over the next several hours to days. Improvement supports shunt responsiveness, but a negative tap test does not completely exclude benefit. External lumbar drainage over several days can increase sensitivity in selected patients when suspicion remains high. CSF infusion testing is used in some centers. The decision for shunting is strongest when the clinical syndrome, imaging, and objective response to CSF removal point in the same direction.
Treatment Strategy & Disposition
Ventriculoperitoneal shunting is the usual definitive treatment for appropriately selected patients. Programmable valves allow postoperative pressure adjustment and can help manage overdrainage complications. Gait tends to improve more reliably than cognition or urinary symptoms, particularly when symptoms have not been longstanding and when comorbid neurodegenerative disease is limited. The aim of evaluation is not to prove that hydrocephalus is the only diagnosis, but to determine whether a clinically important component of disability is likely to improve with CSF diversion.
Before surgery, optimize anticoagulation plans, infection risk, frailty, and comorbid disease. Establish objective baseline gait measures such as timed up-and-go, 10-meter walk, stride length, and turning performance. Cognitive screening and functional history provide a baseline for follow-up but should not substitute for gait assessment. A shunt is not an emergency procedure in typical idiopathic NPH; rushed surgery without a coherent diagnostic workup risks exposing patients with degenerative disease or ex-vacuo ventriculomegaly to complications without meaningful benefit.
After shunting, monitor for subdural hygroma or hematoma, overdrainage headache, infection, obstruction, abdominal complications, and recurrent symptoms. New headache, vomiting, somnolence, focal deficit, fever, redness over the shunt tract, or abrupt loss of prior improvement requires urgent assessment. Rehabilitation remains useful because many patients have deconditioning, balance impairment, and comorbid musculoskeletal limitations even after technically successful CSF diversion.
Epidemiology / Risk Factors
- Idiopathic NPH is primarily a disorder of older adults and is probably underrecognized because its symptoms overlap with common neurodegenerative and musculoskeletal disease.
- Prevalence estimates vary markedly according to diagnostic criteria and population studied.
- Mixed pathology is common, including vascular disease and Alzheimer-type neurodegeneration.
- Because shunting can improve mobility and independence, identifying a treatable NPH component has substantial functional importance.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| MRI brain | Assesses ventriculomegaly, callosal angle, high-convexity sulci, Sylvian fissures, and competing pathology | Ventricular enlargement disproportionate to atrophy with supportive NPH morphology | Preferred when available because it better characterizes white matter and alternative diagnoses |
| CT brain | Demonstrates ventriculomegaly and major structural abnormalities | Enlarged ventricles, sometimes with periventricular change | Useful when MRI is unavailable or contraindicated |
| Large-volume lumbar tap test | Tests short-term functional response to CSF removal | Objective improvement in gait supports shunt responsiveness | Standardize gait testing before and after drainage |
| External lumbar drainage | Provides longer CSF-removal trial when tap test is equivocal | Improvement over several days increases confidence in shunt benefit | Requires monitored placement and carries infection and overdrainage risk |
| Cognitive and functional assessment | Defines baseline deficits and competing dementia syndromes | Frontal-subcortical slowing, executive dysfunction, variable memory impairment | Useful for counseling and postoperative comparison |
| Gait metrics | Quantifies a major treatment target | Slow speed, short stride, prolonged turns, impaired timed up-and-go | Repeat after CSF drainage and after shunting |
Predictive Testing
| Test | Comment |
|---|---|
| Large-volume tap test | Simple outpatient or short-stay test; a clear objective gait response strongly supports shunt candidacy but a negative result is not fully exclusionary |
| External lumbar drainage | Higher-intensity multi-day assessment that can improve sensitivity when the tap test is equivocal |
| CSF infusion or resistance testing | Used in selected specialty centers to characterize CSF dynamics when diagnosis remains uncertain |
| Standardized gait testing | Not a CSF test itself, but essential for interpreting whether drainage produced a meaningful functional response |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| Acetaminophen | Central analgesic | Within an hour | Symptomatic analgesia after lumbar testing or minor postoperative discomfort | Does not treat hydrocephalus itself |
| Perioperative antibiotic prophylaxis | Reduces bacterial inoculation around shunt placement | Hours | Prevention of shunt infection at surgery | Regimen is procedure- and institution-specific |
| Antithrombotic adjustment | Temporarily modifies anticoagulant or antiplatelet effect according to agent | Variable | Reduces procedural bleeding risk when lumbar drainage or shunt surgery is planned | Must balance thrombotic risk and be individualized; not a treatment for NPH |
Prognosis / Complications
- Gait generally improves more often and earlier than cognitive impairment after successful shunting.
- Urinary urgency and continence can improve, particularly when symptoms are not advanced.
- Longstanding severe dementia or major neurodegenerative comorbidity reduces the probability of dramatic cognitive recovery.
- Shunt complications and later mechanical failure can require valve adjustment or revision.
- Objective preoperative response to CSF drainage and a concordant imaging pattern increase confidence in likely benefit but do not guarantee it.
Patient Education / Counseling
- Explain that NPH can resemble dementia or Parkinson disease but is different because CSF diversion may improve symptoms in selected patients.
- Clarify that the goal of a tap test is to predict improvement, especially in walking, rather than to permanently treat the condition.
- Discuss that a negative tap test does not make benefit impossible, but it lowers confidence and may lead to additional testing.
- Review shunt complications including infection, bleeding, overdrainage, obstruction, and the possibility of future revision.
- Set realistic expectations that walking often improves more than memory and that coexisting neurologic disease may remain.
Notes
NPH evaluation is strongest when it is treated as a prediction problem rather than a checklist diagnosis. Ventriculomegaly is common in older adults with cerebral atrophy, and urinary symptoms are common for unrelated reasons. The question is whether the gait and associated syndrome are consistent with hydrocephalus and whether temporary CSF removal produces enough objective improvement to justify the risk of permanent diversion.
No single predictive test is perfect. A positive large-volume tap test is helpful because specificity is reasonably good, but sensitivity is limited. External lumbar drainage can increase confidence in selected patients with a negative or ambiguous tap test. Ultimately the shunt decision should integrate imaging, clinical pattern, objective response, comorbidity, operative risk, and the patient's goals for mobility and independence.
References
- American Academy of Neurology Continuum Review: Management of Normal Pressure Hydrocephalus — Link
- American Academy of Neurology Continuum: Normal Pressure Hydrocephalus — Link
Practice the decision pattern next.
Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.
- Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
- 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
- Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
- CCS cases with live vitals, order timing, reassessment, and after-action feedback